In 2014, Congress passed the Protecting Access to Medicare Act (PAMA) to ensure millions of seniors could maintain access to critical health services, including laboratory tests. Yet, due to misguided implementation, PAMA has led to severe year-over-year cuts to the lab tests that over 56 million seniors rely on under Medicare. Between 2017 and 2022,…
In 2014, Congress passed the Protecting Access to Medicare Act (PAMA) to ensure millions of seniors could maintain access to critical health services, including laboratory tests. Yet, due to misguided implementation, PAMA has led to severe year-over-year cuts to the lab tests that over 56 million seniors rely on under Medicare.
Between 2017 and 2022, payment for common tests for diseases like diabetes, cancer, and heart disease were cut by 27 percent. The next round of Medicare cuts, scheduled to begin January 1, 2023, would slash reimbursement up to another 15 percent for more than 800 laboratory tests, resulting in a staggering 41 percent cut to tests that are widely used to screen and manage many serious diseases. Collectively, these cuts may threaten access to laboratory services for diagnosing and treating seniors across the country.
Without congressional action this year, a fourth round of Medicare cuts are scheduled to begin in January 2023 that could jeopardize access to many clinical laboratory tests used to diagnose, monitor, prevent, and manage common diseases for seniors and all patients across the country.
It is essential that Congress protect patients by acting to fix the Medicare payment model for clinical diagnostic tests. The solution to reforming PAMA is the Saving Access to Laboratory Services Act (SALSA / S. 4449 / H.R. 8188). Congress has acted three times to delay these cuts in recent years, but permanent reform is needed now. The Saving Access to Laboratory Services Act would set Medicare reimbursement back on a sustainable path by updating Medicare’s payment system, which will help protect access to clinical laboratory testing, support investment in innovation, and strengthen America’s clinical laboratory infrastructure.
Click here to visit StopLabCuts.org and learn more about the Saving Access to Laboratory Services Act.
-
Reps. Peters, Bilirakis, Pascrell, Schrader, Holding and Hudson Introduce Bipartisan Legislation to Protect Seniors’ Lab Benefits, Improve Data Reporting Under PAMA
LAB Act (H.R. 3584) would delay PAMA reporting period in order to improve data collection process for market-based rates WASHINGTON, D.C. — With 53 ... Read More -
ACLA Files Reply Brief Ahead of Oral Arguments in ACLA v. Azar Appeal
HHS’ data collection process under PAMA disregards Congressional intent, jeopardizing lab access for millions of seniors Washington, D.C. – The American Clinical Laboratory Association (ACLA) ... Read More -
Leading Health Groups Challenge GAO’s Flawed Report on Medicare Lab Billing
Washington, D.C. – In response to broad and misleading claims in a recent Government Accountability Office (GAO) report, leading clinical laboratory, diagnostic and provider organizations challenged ... Read More -
Letter from Industry Stakeholders in Response to GAO Report on PAMA
-
Seniors managing diabetes are counting on Congress to protect their essential lab services
For America’s seniors, diabetes is now the number one health condition leading to frequent emergency room visits, according to a recent study in the Annals ... Read More -
ACLA Statement on GAO Analysis & Medicare Lab Payments
Latest report reflects misleading, inaccurate assumptions on Medicare lab billing & payment Washington, D.C. – Following the recent release of the Government Accountability Office’s (GAO) report ... Read More -
For patients, PAMA reforms can’t wait
As we gaveled in a new Congress this month, protecting lab services for America’s seniors has never been more important. A recent piece in the ... Read More -
ACLA Files Appeal in ACLA v. Azar, Asks U.S. Court of Appeals to Address HHS’s Overreach in Data Reporting
HHS’s continued flawed implementation of PAMA threatens beneficiaries’ access to critical lab services Washington, D.C. – Today, the American Clinical Laboratory Association (ACLA) advanced its ... Read More -
ACLA Appellant/Petitioner Brief: American Clinical Laboratory Association v. Alex Azar
-
In a divided Washington, protecting seniors’ health care is an issue where everyone agrees
As lawmakers work to advance final legislative proposals, Congress has the chance to take decisive action on one issue that has bipartisan support: protecting seniors’ ... Read More